|
|
||||||||
Departments of 1 Autonomic Physiology and 2 Molecular and Integrative Physiology, Graduate School of Medicine, Chiba University, Chiba-city, Chiba 260-8670, Japan
| |
ABSTRACT |
|---|
|
|
|---|
Sleep apnea occurs in humans and experimental animals. We examined whether it also arises in adult mice. Ventilation in male adult 129/Sv mice was recorded concomitantly by electroencephalograms and electromyograms for 6 h by use of body plethysmography. Apnea was defined as cessation of plethysmographic signals for longer than two respiratory cycles. While mice breathed room air, 32.3 ± 6.9 (mean ± SE, n = 5) apneas were observed during sleep but not in quiet awake periods. Sleep apneas were further classified into two types. Postsigh apneas occurred exclusively during slow-wave sleep (SWS), whereas spontaneous apneas arose during both SWS and rapid eye movement sleep. Compared with room air (9.1 ± 1.4/h of SWS), postsigh apneas were more frequent in hypoxia (13.7 ± 2.1) and less frequent in hyperoxia (3.6 ± 1.7) and hypercapnia (2.8 ± 2.1). Our data indicated that significant sleep apnea occurs in normal adult mice and suggested that the mouse could be a promising experimental model with which to study the genetic and molecular basis of respiratory regulation during sleep.
sleep apnea syndromes; respiration; control of breathing; whole body plethysmography
| |
INTRODUCTION |
|---|
|
|
|---|
SLEEP APNEA SYNDROME,
defined as an apnea-hypopnea index of
5 associated with daytime
hypersomnolence, is estimated to affect 4% of men and 2% of women
(38). Sleep apnea is classified into obstructive, central,
and mixed types. Obstructive sleep apnea is characterized by repetitive
obstruction of the upper airway during sleep, whereas central sleep
apnea is characterized by recurrent apneic episodes in the absence of
upper airway obstruction (1). Although some patients with
obstructive sleep apnea may be treated with continuous positive airway
pressure (5), the exact cause(s) of both obstructive sleep
apnea and central sleep apnea has not been fully elucidated.
Several animal models of sleep apnea have been described over the past two decades. These have included sleep-triggered mechanical airway occlusion in dogs (16), exposure to hypoxic gas in mice (34), and artificially induced central apnea in lambs (20). In addition, English bulldogs (13) and rats (6, 25, 33) develop sleep apnea without artificial maneuvers. Among these models, the rat is of particular interest because sleep apnea occurs not only in sleep apnea syndrome patients but also in normal humans (2, 18, 38). Whether normal mice suffer from sleep apnea without artificial maneuvers remains unknown.
We studied apnea in mice because these animals are frequently used in genetic engineering. The use of transgenic mice has already allowed the effects of specific genes on physiological functions to be studied. In fact, the sleep-wake state and ventilation in mice have been simultaneously recorded, for example, to characterize the roles of leptin in respiratory depression with obesity (28). However, sleep apnea in mice has not been documented to our knowledge, and the identification of sleep apnea in normal mice might help to understand the molecular basis of sleep apnea.
The aims of the present study were 1) to examine whether normal mice develop apnea during sleep and, if so, 2) to examine the effect of respiratory chemostimulation on sleep apnea. The second aim was based on studies indicating that an elevated CO2 threshold (lowest CO2 concentration that triggers respiration) during sleep could trigger sleep apnea (7).
| |
METHODS |
|---|
|
|
|---|
Mice and surgical procedure. Male 129/Sv mice (23-33 wk old at the time of surgery, weighing 27-33 g, average 31 g, n = 5) were anesthetized with 2-3% isoflurane. Electrodes for electroencephalography (EEG) and electromyography (EMG) were implanted at a body temperature of 36-38°C (Physitemp Instruments, Clifton, NJ). For EEG recording, stainless steel screws were implanted bilaterally into the parietal bones of the skull at 2 mm lateral and 2 mm posterior to the bregma while the head was immobilized with a stereotaxic frame (Stoelting, Wood Dale, IL). Two electrodes for EMG recording were also implanted into the nuchal muscle. In one additional animal, an EMG of the external intercostal muscle in the eighth intercostal space was recorded instead of the EEG and the neck EMG to examine whether the absence of a plethysmographic signal (i.e., apnea, see Definition of apnea) was associated with the disappearance of an EMG signal from the respiratory muscles. These electrodes were soldered to a four-channel connector plug (MT Giken, Tokyo, Japan) that was firmly fixed to the skull with dental cement. An antibiotic (cephazolin, 100 mg/kg) was subcutaneously administered before and after the surgery. The mice were housed individually after surgery in a temperature-controlled room (23-25°C) under a 12:12-h light-dark cycle (lights on at 0600). Food and water were available ad libitum. All experimental procedures proceeded in accordance with the "Guiding Principles for the Care and Use of Animals in the Field of Physiological Sciences" recommended by the Physiological Society of Japan.
Measurement of EEG and definition of sleep stages. Mice were allowed to recover from surgery for at least 7 days before experiments. This period was selected on the basis of preliminary studies of four mice showing that apnea initially appeared 3-4 days after surgery, increased toward 7 days, and remained constant thereafter. Breathing was measured by body plethysmography (see Measurement of ventilation) in a free-running state, together with the EEG and EMG. To allow freedom of movement during recording, a slip-ring (MSR35, MT Giken) was placed at the connection of the electrodes to lines outside the plethysmograph. The EEG and EMG signals were amplified (with band-pass filters for EEG, 0.25-100 Hz; for neck EMG, 15-100 Hz; for intercostal EMG, 200-1,000 Hz) (AB-651J, Nihon Kohden, Tokyo, Japan) and fed into a personal computer (Macintosh, Apple Computer) after analog-to-digital conversion (MacLab, ADInstruments, Castle Hill, NSW, Australia) at a sampling frequency of 200 Hz (for EEG and neck EMG) or 4,000 Hz (for intercostal EMG). Neck EMG and intercostal EMG were digitally filtered (FIR filter, band pass 15-100 Hz and 200-1,000 Hz, respectively) and used for later analysis. Sleep architecture was determined by visual inspection of the neck EMG and digitally filtered EEG (0.25-4, 4-8, and 8-30 Hz). Waveforms were displayed on a wide screen at a resolution of ~5 mm/s, and transitions among vigilance states were judged by relative changes in amplitude. For every 5-s epoch, vigilance was scored as a predominant state by use of the following criteria. Quiet wakefulness (QW) was defined by a high-frequency (8-30 Hz) low-amplitude EEG with a relatively high EMG tone. Active wakefulness (AW) was defined by very-high-amplitude EMG volleys. EMG-based discrimination between QW and AW was confirmed by visual inspection of videotaped behavior of the mouse. Slow wave sleep (SWS) was defined by a low-frequency (0.25-4 Hz) high-amplitude EEG. Non-SWS sleep or rapid eye movement (REM) sleep was defined by a mixed-frequency (4-8 and 8-30 Hz) low-amplitude EEG associated with weak or absent EMG activity. Two investigators (A. Nakawana and T. Kuwaki) individually scored all recordings. The initial agreement was over 90%, and disagreements were resolved by classifying the segments with reference to the average amplitudes of the EEG and EMG.
Measurement of ventilation by whole body plethysmography. We used double-chamber whole body plethysmography (10, 27, 29) with few modifications, as described by Jacky (15). One chamber (750 ml) was used as a barometric chamber where the mouse was placed, and reference pressure was measured in the other. The outlet ports of both chambers were connected by a long tube so that the time constant for gas leakage from the chamber was large compared with the duration of the respiratory cycle. Such modification allowed both respiratory frequency (fR) and tidal volume (VT) to be measured by the flow-through system (15). Plethysmographic signals were recorded as changes in the pressure difference between the two chambers by use of a differential pressure transducer (TP-602T, Nihon Kohden). Amplified (AR-601G and AB-621G, Nihon Kohden) signals were fed into a computer (sampling frequency of 100 Hz) together with EEG and EMG signals as described above. The fR and amplitude of the plethysmographic signals (representing VT) were calculated by use of the signal analysis software, Chart (ADInstruments). Ambient temperature and pressure and the chamber temperature were measured intermittently (about every 2 h) during the 6 h of recording, and the average values were used for later calculation of VT. Chamber temperature in the thermoneutral range was maintained between 22 and 25°C by controlling the room temperature to minimize possible metabolic effects on respiration. Animal core temperature was not measured continuously. Instead, the rectal temperature of each mouse was recorded immediately after the plethysmographic recording. Individual measurements of rectal temperature revealed a mean value (±SE) of 35.8 ± 0.7°C, which did not significantly differ among four gas conditions (see below). On the basis of these values, the VT value was calculated according to the formula used by Epstein et al. (10). Minute volume (MV) was defined as the product of inspiratory VT and fR. In addition, the coefficients of variance (CV = SD/average) of VT and fR were calculated to evaluate the regularity of respiration at each sleep stage. Respiratory parameters including apneas were calculated for QW, SWS, and REM but not for AW because breathing varied widely during various behaviors (e.g., walking, grooming) in AW and hence values in AW would not be suitable as controls for those in sleep stages.
All recordings were obtained over 6 h between 1000 and 1600, which is the resting period for nocturnal mice (26). During the entire recording period, mice were allowed to move freely. Each chamber was continuously flushed with a gas mixture at a rate of 500 ml/min, either room air or hypoxic (15% O2 balance with N2), hyperoxic (100% O2), or normoxic hypercapnic (5% CO2-21% O2-N2 balance) gas mixtures. Chamber PCO2 and PO2 values were continuously monitored (Respina IH26, NEC-San-Ei-Instruments, Tokyo, Japan) at the outlet of the chamber, and we confirmed that the flushing rate in this study was sufficient to avoid both CO2 accumulation and an O2 decrease in the chamber while animals breathed room air. Each animal was tested under all four air conditions in a random order over 4-7 days.Definition of apnea. Apnea was defined as a cessation of plethysmographic signals for at least two respiratory cycles, similar to the criterion used for sleep apnea in humans (cessation of breathing for >10 s, which is one or two missed breaths). The duration of the basal respiratory cycle was calculated as the mean value of stable breaths during the 10-20 s just before the apnea. Similar to previous reports (4, 6) of periodic respiration and sleep apneas in rats, apneas were classified as postsigh if the preceding breath was at least 25% above the average amplitude during the preceding 10 s (see Fig. 2, B and D). Apnea without a preceding sigh was defined as spontaneous. The duration of apnea was evaluated not only by an absolute length of time but also as the ratio of each apnea period to the respiratory cycle period adjacent to the apnea (termed "apnea duration index"), because the length of cycle time significantly differed among the gas conditions (see RESULTS). The "apnea occurrence index," defined as the number of apneic episodes per hour, was separately calculated for each type of apnea during each stage of sleep.
Statistical analyses. All data are expressed as means ± SE. The effects of the inspired gas composition on the appearance of apnea, sleep state, and basal respiratory parameters (VT, fR, and MV) were assessed by ANOVA with a repeated measures design, in which room air was treated as the control. Differences in respiratory parameters among vigilance states (QW, SWS, and REM sleep) were also analyzed by use of ANOVA with repeated measures. A P value below 0.05 denoted a statistically significant difference.
| |
RESULTS |
|---|
|
|
|---|
Basic parameters of ventilation and sleep-wake state.
To examine whether normal mice develop sleep apnea, we continuously and
concomitantly measured ventilation and the vigilance state for 6 h
when the animals were at rest. When breathing normal room air, the mice
spent 54.4 ± 3.9% of the recording period sleeping (both SWS and
REM sleep, Table 1). The inhalation of
hypoxic, hyperoxic, or hypercapnic gas mixtures did not affect the
total amount of sleep, compared with room air (Table 1). Unlike humans but very similar to rats, SWS and wake episodes were highly fragmented, and the duration of SWS varied widely within each animal even under a
specific gas condition. Consequently, sleep architecture did not
significantly differ among the four gas conditions (Fig. 1).
|
|
|
|
Parameters of apnea while breathing room air.
In mice breathing room air, 32.3 ± 6.9 (n = 5)
instances of apnea were recorded during the 6-h observation period
(Table 4). Apneas were detected during
sleep and never during QW periods. Sleep apneas were classified as
postsigh and spontaneous types (Fig. 2).
Most instances of postsigh apnea (>99.5%) did not begin immediately
after sighs but after a lag period of several normal (or diminished)
breaths (Fig. 2, B and D). The cessation of
respiratory signals in whole body plethysmography was accompanied by
the disappearance of intercostal EMG traces (Fig. 2, C and
D), indicating that these types of apnea were central rather
than obstructive. Intercostal EMG recordings during both types of apnea
similarly disappeared when the animal breathed hypoxic, hyperoxic, and
hypercapnic gas mixtures (data not shown).
|
|
|
|
Effect of inspired gas on apnea. A comparison of breathing patterns under the four gas conditions showed that the relationship between the type of apnea and sleep stage was generally conserved at least for postsigh apneas. Specifically, postsigh apneas occurred exclusively during SWS under every gas condition (Table 4). However, the apnea occurrence index was significantly dependent on the gas condition (Fig. 3). Hypoxia induced about a 50% increase in postsigh apneas, whereas hyperoxia and hypercapnia resulted in a 60-70% decrease compared with postsigh apneas in room air. The tendency of the spontaneous apnea occurrence index in REM sleep was similar, although the difference was not statistically significant because of a large variability (Fig. 3). The difference in the postsigh apnea occurrence index in SWS was not tightly associated with the occurrence of sigh per se (Fig. 3) but was somewhat correlated with the ratio of sighs followed by apnea to an entire sigh (Table 4).
Apnea duration and fR were reciprocally related. Thus the apnea duration indexes (for both postsigh and spontaneous types of apnea) did not significantly differ among the four gas conditions (Fig. 4). The mean apnea duration indexes were ~3-5, representing an absence of 2-4 expected breaths in each apnea irrespective of the gas condition or type of apnea. Finally, the total period in which the mice underwent postsigh apnea per hour tended to be longer in hypoxia, shorter in hyperoxia, and significantly shorter in hypercapnia compared with the corresponding values recorded under room air (Fig. 5). The tendency for spontaneous apnea was similar during REM sleep.
|
| |
DISCUSSION |
|---|
|
|
|---|
We investigated breathing instability during sleep in normal mice to examine whether this species is suitable for studies on sleep apnea. The major findings of the present study were as follows. 1) Episodes of apnea are frequent in normal mice during daytime sleep. 2) Sleep apneas could be classified into two types, postsigh and spontaneous apneas. Postsigh apneas occurred exclusively in SWS, although sighs without subsequent apnea arose during both SWS and REM sleep. 3) Chemostimulation by hypoxia increased the occurrence of the postsigh apnea index during SWS. In contrast, chemostimulation by hypercapnia decreased the index. The tendency of the spontaneous apnea occurrence index during REM sleep was similar. 4) The duration of apnea was equivalent to three to five respiratory cycle periods, irrespective of the basal fR or type of apnea.
Effects of inspired gas composition on sleep-wake state. Under room air breathing, the amount of total sleep and the duration of each vigilance state recorded in our study (Table 1, Fig. 1) were within the range of those identified in mice by recording only the EEG (11, 24, 36, 37), in which the REM fraction varied among the studies as 1-10%. The low REM fraction in our study (1.7%) might have resulted from the fact that the recording chamber was not the home cage. However, repeated measurements did not appear to change the REM fraction in our preliminary experiment, indicating that acclimatization to the recording chamber did not affect the REM fraction. Rather, variations in the REM fraction among the reports may have resulted from variations in the techniques used to measure EEG and to judge vigilance states in mice. For example, the position of electrodes, classification of EEG band frequencies, algorithm of the judgment, minimal duration of a vigilance state, and their combination varied among the studies. These should be considered when comparing results from various laboratories because EEG recording in mice has not been standardized. Nevertheless, our data indicated that being placed in the whole body plethysmography chamber over a long period seemed not to seriously affect the vigilance state. Moreover, the sleep-wake state was not significantly affected by changes in the inspired gas composition. This result was in concert with those in rats (21, 30), although more severe hypoxia (10% O2) distorts sleep and lengthens wakefulness (12). The degrees of both hypoxia (15% O2) and hypercapnia (5% CO2) in the present study were thought to be mild enough not to affect the sleep-wake state. This might be also interpreted to mean that the observed change in apnea according to the inspired gas composition (see below) was not likely to be due to a change in sleep architecture.
Effects of inspired gas composition on respiratory variables. Although hypoxic and hypercapnic stimuli did not result in any apparent effect on sleep architecture, they clearly stimulated respiration, as evident by changes in the fR, VT, and MV values (Table 2). Moreover, these values depended not only on the composition of the inspired gas but also on the vigilance states. The smaller fR, VT, and MV during SWS compared with QW in our mice were consistent with the findings in humans (17). In our study, the VT value during REM further decreased compared with SWS, whereas the MV value during REM was not significantly different from that during SWS. This finding was also in agreement with those of human studies (9, 17). In both humans (8) and mice (28), the ventilatory responses to acute hypoxia and hypercapnia were the largest during wakefulness and the lowest during REM sleep. Our results extended these findings to long-term hypoxic/hypercapnic stimulation (Table 2).
Similar to previous findings in humans (17), breathing was most regular during SWS among three vigilance states (Table 3). The rank order of CV in fR was hyperoxia > hypoxia > = room air > hypercapnia during SWS, whereas that of the apnea occurrence index (Fig. 3) was hypoxia > room air > hyperoxia > = hypercapnia. This means that the basic and overall regularity of breathing does not predict the occurrence of apneas. During QW, the CVs of fR and VT under hypercapnia were smaller than those under room air, indicating that chemoreflex activation overcame other sources of irregularity such as emotion under hypercapnia.Characteristics of apnea in mice. The numbers of sighs and episodes of apnea during the entire recording period (Table 4) closely matched those found in rats (6). The 129/Sv mouse strain might be susceptible to sleep apnea because basic respiratory parameters and ventilatory responses to chemoreceptor stimulation vary among strains of mice (29, 35). However, our preliminary results found no apparent differences between 129/Sv and C57BL6/J mice, which are two major strains that are frequently used in studies of gene targeting.
Both the postsigh and spontaneous types of apnea identified in this study were probably central sleep apnea because no apparent intercostal EMG (Fig. 2) indicated absence of the paradoxical thoracic movement that arises during obstructive sleep apnea. This type of apnea is unlikely to occur in four-footed animals because of the straighter arrangement of the nasal cavity and pharynx than in upright animals such as humans. In fact, the only four-footed animal that is known to develop obstructive sleep apnea is the English bulldog (13), but this is related to the nature of the facial and upper airway structures. The absence of free-floating hyoid arches may also contribute to the absence of obstructive sleep apnea in rodents. Postsigh apneas exclusively arose during SWS irrespective of gas conditions, although sighs without subsequent apnea developed during both SWS and REM sleep (Table 4, Fig. 3). On the other hand, spontaneous apnea was not clearly related to sleep stages. Therefore, a sigh-apnea coupling mechanism(s) in mice might be dependent on the sleep state. The present study simply classified apneas into two types according to the presence or absence of a preceding sigh. However, postsigh apneas in humans have been further classified into those that follow several normal breaths after an augmented breath (type 1) and those immediately after a sigh (type 2) (14, 32). Moreover, spontaneous apneas have also been classified into those with neither a preceding nor subsequent sigh (type 3) and those followed by an augmented breath(s) (type 4). Although the rationale for such classification is not clear, we also observed these types of apneas in mice (type 1 accounted for 99.5% of total of postsigh apneas and type 3 was over 99% of that of spontaneous apneas; Fig. 2).Relationship between apneas and inspired gas composition. Figure 3 shows that hypoxic stimulation increased the postsigh apnea occurrence index during SWS. Conversely, chemoreceptor activation during hypercapnia decreased the postsigh apnea occurrence index during SWS. The tendency for spontaneous apnea to occur during REM sleep was similar, although the data were inconclusive because of the low number of recorded episodes of spontaneous apnea. Thus respiratory stimulation induced by different chemoreceptor inputs results in opposite effects with regard to the occurrence of apnea. The increase in the occurrence of apnea induced by hypoxia was in agreement with that in normal humans (3, 19) but not in rats (6). Hyperoxia reduced the occurrence of apnea in the present study, which was also in agreement with the findings in patients with central apneas (22) but not in those with obstructive apnea in whom supplemental O2 rather increased the occurrence or prolonged the duration of apnea (22, 23).
In general, apneas after an overshoot are thought to result from hypocapnia (7). In our study, however, postsigh apneas developed during SWS even under hypercapnia. This finding suggests that postsigh apneas in mice did not result solely from hypocapnia induced by hyperventilation. Other possible causes of postsigh apneas include mechanoreceptor activation by augmented breaths, which may actively suppress the subsequent respiratory drive within the neural circuitry as with the persistent inhibition in the Hering-Breuer reflex (7). In fact, our preliminary experiments found that anesthesia significantly suppressed the ratio of apneas to sighs but did not affect the occurrence or numbers of sighs, emphasizing the importance of neural factors in sigh-apnea coupling. Our observation of a hypoxia-induced increase in postsigh apneas could also be explained by hyperventilation-induced hypocapnia under this condition. However, a decrease in arterial PCO2 (PaCO2) becomes apparent when inspired PO2 is <13% in rats (31). Because we used an inspired PO2 of 15% in our study, the decrease in PaCO2 would be too moderate to trigger sleep apnea by itself. Rather, a combination of a small decrease in PaCO2, a small increase in the apnea threshold (PaCO2 below that required to induce apnea; Ref. 7), and a mild strengthening of sigh-apnea coupling (see Table 4) seemed to increase the incidence of postsigh apnea induced by hypoxia. The decrease in the incidence of apnea under hyperoxia in the present study also supports our view that not only PaCO2 but also neural mechanisms controlling sigh-apnea coupling might play a key role in the development of sleep apnea. PaCO2 theory alone cannot explain why the duration of apnea was equal to three to five respiratory cycle periods irrespective of basal fR or type of apnea (Fig. 4). This is because PaCO2 accumulation during the apneic period should depend on the duration of apnea and not on the index of the apnea duration. Nevertheless, it would be necessary to evaluate breath-by-breath PaCO2 before making any conclusions on this issue. In conclusion, the present study demonstrated that a significant amount of sleep apnea occurs in normal mice as it does in rats and humans. We therefore believe that mice constitute a suitable animal model with which to study the genetic and molecular mechanisms involved in the regulation and dysregulation of breathing.| |
ACKNOWLEDGEMENTS |
|---|
We thank Chikako Kumagai and Wataru Nakamura for excellent technical assistance. We also thank Dr. Faiq G. Issa and Dr. Megumi Shimoyama for help in editing the manuscript.
| |
FOOTNOTES |
|---|
Part of this work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan and by grants from the Shimadzu Science Foundation and the Yamanouchi Foundation for Research on Metabolic Disorders.
Address for reprint requests and other correspondence: T. Kuwaki, Dept. of Molecular and Integrative Physiology, Graduate School of Medicine, Chiba Univ., 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan (E-mail: kuwaki{at}faculty.chiba-u.jp).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
First published October 25, 2002;10.1152/japplphysiol.00226.2002
Received 15 March 2002; accepted in final form 11 October 2002.
| |
REFERENCES |
|---|
|
|
|---|
1.
American Academy of Sleep Medicine Task Force.
Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research.
Sleep
22:
667-689,
1999.
2.
Block, AJ,
Boysen PG,
Wynne JW,
and
Hunt LA.
Sleep apnea, hypopnea and oxygen desaturation in normal subjects. A strong male predominance.
N Engl J Med
300:
513-517,
1979.
3.
Carley, DW,
and
Shannon DC.
Relative stability of human respiration during progressive hypoxia.
J Appl Physiol
65:
1389-1399,
1988.
4.
Carley, DW,
Trbovic SM,
and
Radulovacki M.
Hydralazine reduces elevated sleep apnea index in spontaneously hypertensive (SHR) rats to equivalence with normotensive Wistar-Kyoto rats.
Sleep
19:
363-366,
1996.
5.
Chin, K,
Shimizu K,
Nakamura T,
Narai N,
Masuzaki H,
Ogawa Y,
Mishima M,
Nakao K,
and
Ohi M.
Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy.
Circulation
100:
706-712,
1999.
6.
Christon, J,
Carley DW,
Monti D,
and
Radulovacki M.
Effects of inspired gas on sleep-related apnea in the rat.
J Appl Physiol
80:
2102-2107,
1996.
7.
Dempsey, JA,
Smith CA,
Harms CA,
Chow C,
and
Saupe KW.
Sleep-induced breathing instability. University of Wisconsin-Madison Sleep and Respiration Research Group.
Sleep
19:
236-247,
1996.
8.
Douglas, NJ.
Respiratory physiology: control of ventilation.
In: Principles and Practice of Sleep Medicine (3rd ed.), edited by Krygler MH,
Roth T,
and Dement WC.. Philadelphia, PA: Saunders, 2000, p. 221-228.
9.
Douglas, NJ,
White DP,
Pickett CK,
Weil JV,
and
Zwillich CW.
Respiration during sleep in normal man.
Thorax
37:
840-844,
1982.
10.
Epstein, RA,
Epstein MA,
Haddad GG,
and
Mellins RB.
Practical implementation of the barometric method for measurement of tidal volume.
J Appl Physiol
49:
1107-1115,
1980.
11.
Franken, P,
Malafosse A,
and
Tafti M.
Genetic variation in EEG activity during sleep in inbred mice.
Am J Physiol Regul Integr Comp Physiol
275:
R1127-R1137,
1998.
12.
Hamrahi, H,
Stephenson R,
Mahamed S,
Liao KS,
and
Horner RL.
Regulation of sleep-wake states in response to intermittent hypoxic stimuli applied only in sleep.
J Appl Physiol
90:
2490-2501,
2001.
13.
Hendricks, JC,
Kline LR,
Kovalski RJ,
O'Brien JA,
Morrison AR,
and
Pack AI.
The English bulldog: a natural model of sleep-disordered breathing.
J Appl Physiol
63:
1344-1350,
1987.
14.
Hoch, B,
Bernhard M,
and
Hinsch A.
Different patterns of sighs in neonates and young infants.
Biol Neonate
74:
16-21,
1998.
15.
Jacky, JP.
A plethysmograph for long-term measurements of ventilation in unrestrained animals.
J Appl Physiol
45:
644-647,
1978.
16.
Kimoff, RJ,
Makino H,
Horner RL,
Kozar LF,
Lue F,
Slutsky AS,
and
Phillipson EA.
Canine model of obstructive sleep apnea: model description and preliminary application.
J Appl Physiol
76:
1810-1817,
1994.
17.
Krieger, J.
Respiratory physiology: breathing in normal subjects.
In: Principles and Practice of Sleep Medicine (3rd ed.), edited by Krygler MH,
Roth T,
and Dement WC.. Philadelphia, PA: Saunders, 2000, p. 229-241.
18.
Krieger, J,
Turlot JC,
Mangin P,
and
Kurtz D.
Breathing during sleep in normal young and elderly subjects: hypopneas, apneas, and correlated factors.
Sleep
6:
108-120,
1983.
19.
Lahiri, S,
and
Edelman NH.
Peripheral chemoreflexes in the regulation of breathing of high altitude natives.
Respir Physiol
6:
375-385,
1969.
20.
Lamaire, D,
Letourneau P,
Dorion D,
and
Praud JP.
Complete glottic closure during central apnea in lambs.
J Otolaryngol
28:
13-19,
1999.
21.
Laszy, J,
and
Sarkadi A.
Hypoxia-induced sleep disturbance in rats.
Sleep
13:
205-217,
1990.
22.
Longobardo, GS,
Gothe B,
Goldman MD,
and
Cherniack NS.
Sleep apnea considered as a control system instability.
Respir Physiol
50:
311-333,
1982.
23.
Martin, RJ,
Sanders MH,
Gray BA,
and
Pennock BE.
Acute and long-term ventilatory effects of hyperoxia in the adult sleep apnea syndrome.
Am Rev Respir Dis
125:
175-180,
1982.
24.
Meerlo, P,
Easton A,
Bergmann BM,
and
Turek FW.
Restraint increases prolactin and REM sleep in C57BL/6J mice but not in BALB/cJ mice.
Am J Physiol Regul Integr Comp Physiol
281:
R846-R854,
2001.
25.
Mendelson, WB,
Martin JV,
Perlis M,
Giesen H,
Wagner R,
and
Rapoport SI.
Periodic cessation of respiratory effort during sleep in adult rats.
Physiol Behav
43:
229-234,
1988.
26.
Mitler, MM,
Lund R,
Sokolove PG,
Pittendrigh CS,
and
Dement WC.
Sleep and activity rhythms in mice: a description of circadian patterns and unexpected disruptions in sleep.
Brain Res
131:
129-145,
1977.
27.
Nakamura, A,
Kuwaki T,
Kuriyama T,
Yanagisawa M,
and
Fukuda Y.
Normal ventilation and ventilatory responses to chemical stimuli in juvenile mutant mice deficient in endothelin-3.
Respir Physiol
124:
1-9,
2001.
28.
O'Donnell, CP,
Schaub CD,
Haines AS,
Berkowitz DE,
Tankersley CG,
Schwartz AR,
and
Smith PL.
Leptin prevents respiratory depression in obesity.
Am J Respir Crit Care Med
159:
1477-1484,
1999.
29.
Onodera, M,
Kuwaki T,
Kumada M,
and
Masuda Y.
Determination of ventilatory volume in mice by whole body plethysmography.
Jpn J Physiol
47:
317-326,
1997.
30.
Pappenheimer, JR.
Sleep and respiration of rats during hypoxia.
J Physiol
266:
191-207,
1977.
31.
Pepelko, WE,
and
Dixon GA.
Arterial blood gases in conscious rats exposed to hypoxia, hypercapnia, or both.
J Appl Physiol
38:
581-587,
1975.
32.
Perez-Padilla, R,
West P,
and
Kryger MH.
Sighs during sleep in adult humans.
Sleep
6:
234-243,
1983.
33.
Sato, T,
Saito H,
Seto K,
and
Takatsuji H.
Sleep apneas and cardiac arrhythmias in freely moving rats.
Am J Physiol Regul Integr Comp Physiol
259:
R282-R287,
1990.
34.
Tagaito, Y,
Polotsky VY,
Campen MJ,
Wilson JA,
Balbir A,
Smith PL,
Schwartz AR,
and
O'Donnell CP.
A model of sleep-disordered breathing in the C57BL/6J mouse.
J Appl Physiol
91:
2758-2766,
2001.
35.
Tankersley, C,
Fitzgerald R,
and
Kleeberger S.
Differential control of ventilation among inbred strains of mice.
Am J Physiol Regul Integr Comp Physiol
267:
R1371-R1377,
1994.
36.
Tobler, I,
Deboer T,
and
Fischer M.
Sleep and sleep regulation in normal and prion protein-deficient mice.
J Neurosci
17:
1869-1879,
1997.
37.
Veasey, SC,
Valladares O,
Fenik P,
Kapfhamer D,
Sanford L,
Benington J,
and
Bucan M.
An automated system for recording and analysis of sleep in mice.
Sleep
23:
1025-1040,
2000.
38.
Young, T,
Palta M,
Dempsey J,
Skatrud J,
Weber S,
and
Badr S.
The occurrence of sleep-disordered breathing among middle-aged adults.
N Engl J Med
328:
1230-1235,
1993.
This article has been cited by other articles:
![]() |
J. Terada, A. Nakamura, W. Zhang, M. Yanagisawa, T. Kuriyama, Y. Fukuda, and T. Kuwaki Ventilatory long-term facilitation in mice can be observed during both sleep and wake periods and depends on orexin J Appl Physiol, February 1, 2008; 104(2): 499 - 507. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-S. Deng, A. Nakamura, W. Zhang, M. Yanagisawa, Y. Fukuda, and T. Kuwaki Contribution of orexin in hypercapnic chemoreflex: evidence from genetic and pharmacological disruption and supplementation studies in mice J Appl Physiol, November 1, 2007; 103(5): 1772 - 1779. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hayasaka, T. Yaita, T. Kuwaki, S. Honma, K.-i. Honma, T. Kudo, and S. Shibata Optimization of Dosing Schedule of Daily Inhalant Dexamethasone to Minimize Phase Shifting of Clock Gene Expression Rhythm in the Lungs of the Asthma Mouse Model Endocrinology, July 1, 2007; 148(7): 3316 - 3326. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nakamura, W. Zhang, M. Yanagisawa, Y. Fukuda, and T. Kuwaki Vigilance state-dependent attenuation of hypercapnic chemoreflex and exaggerated sleep apnea in orexin knockout mice J Appl Physiol, January 1, 2007; 102(1): 241 - 248. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Popa, C. Lena, V. Fabre, C. Prenat, J. Gingrich, P. Escourrou, M. Hamon, and J. Adrien Contribution of 5-HT2 Receptor Subtypes to Sleep-Wakefulness and Respiratory Control, and Functional Adaptations in Knock-Out Mice Lacking 5-HT2A Receptors J. Neurosci., December 7, 2005; 25(49): 11231 - 11238. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, S. Inoue, J. Gu, E. Miyoshi, K. Noda, W. Li, Y. Mizuno-Horikawa, M. Nakano, M. Asahi, M. Takahashi, et al. From The Cover: Dysregulation of TGF-{beta}1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice PNAS, November 1, 2005; 102(44): 15791 - 15796. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |